Meet Addie “The Face of the CMT Medical Journal”

by | May 6, 2021 | 0 comments

Meet Addie “The Face of the CMT Medical Journal”

 

In the Fall CMTUpdate, the feature article announced that HNF, in partnership with CaptureProof, is bringing innovative and powerful computer learning capabilities to give you the power to capture and document your CMT story with photos and videos to improve the health care you receive. We’re calling the project, The CMT Medical Journal. When it came time to film the tutorial videos for the project, we knew we wanted Addie to be “The Face of the CMT Medical Journal”. With coaching from Leslie Nelson, PT, Ph.D., Board Certified Specialist in Orthopedic Physical Therapy, and Assistant Professor at UT Southwestern School of Health Professions Department of Physical Therapy, Addie demonstrates each of the exercises in the protocol like a pro! 

Addie is 11 years old and lives in Austin, Texas. When she was 4 years old her parents noticed that she was walking oddly and after many doctor visits and testing she was diagnosed at 6 years old with CMT1A. We had a candid conversation with Addie about life with CMT and here’s what she told us, in her own words:

Having a CMT diagnosis is really interesting and rewarding. I have the ability to expand other people’s knowledge about CMT. At times CMT is difficult for me, my mom often helps me tie my shoes as I get ready for school. My friends run ahead of me and typing on the computer is challenging. My teacher often will type my notes for me.

There are many activities that I participate in that are complementary to my CMT: dance, swimming, and acting.

One thing I like least about CMT is the odd looks people give me when I use the elevator at school. Also, it’s sometimes hard to keep up with my friends. I do have some dedicated friends that offer to go down the elevator with me and hold books that don’t fit in my backpack.  

Recently, my parents applied for a disabled parking sticker so when we go to the store or outdoor music festivals we can park closer to conserve my energy. On days when CMT is hard for me, I use CBD medicine. I have it on my nightstand and in my dance bag that way I can apply somewhere needed and go on with my day.

One thing I found useful is a backpack on wheels so I can roll it in school. My bike is a pink  three-wheeler(my friends are super jealous)

Explaining CMT to my friends is hard because when I’m just standing, I seem normal, but I try to explain that this disease makes your hands & feet hurt.

My hope for the CMT Medical Journal project is that once in a million years there is a cure for CMT so that other people with CMT can have the cure. My case is not as severe. I’m lucky!

Thanks, Addie. You are a superstar! 

If you want to create a visual medical journal that will capture, in sensitive detail, the daily struggles and challenges of living with CMT, please let us know that you are interested by joining the waiting list by emailing [email protected]. We’ll be in touch with an invitation to participate when there is an opening.

Learn more on this topic

Related Blog Posts

Support CMT Therapeutic Alliance

HNF has entered into a joint venture – the CMT Therapeutic Alliance – with a unique non profit organization (BioPontis Alliance for Rare Diseases) that brings professional drug discovery capabilities to translate our research results into potential treatments.

Sneak Peak of Fall Newsletter: CMT Research Study Survey

My name is Elizabeth Francisco and I am a graduate student from the Genetic Counseling program at the University of North Carolina Greensboro. I am inviting you to participate in a research study. The goal of my study is to learn more about the experiences of people with Charcot-Marie-Tooth (CMT) with genetic counseling and genetic testing. Adults with CMT and parents or legal guardians of someone of any age who has a diagnosis of CMT are eligible to participate

Building Awareness on CMT and Supporting the Patient Community – HNF Announces Support from Pharnext

HNFpharnext recently entered into a partnership with the French biopharmaceutical company, Pharnext, to help raise awareness of Charcot-Marie-Tooth (CMT) disease and support the CMT patient community through several initiatives. Building awareness is key! Pharnext’s support will assist HNF in distributing HNF’s CMT Update quarterly newsletter, enhancing the Global Registry for Inherited Neuropathies (GRIN), setting up activities for CMT September Awareness Month in the US and strengthening the CMT Inspire Community.

Quality of Life and CMT Research

Did you know that 95% of clinical trials fail? There are multiple causes, most related to efficacy or safety, which obviously can be harmful and risky for patients. The risk-reward of enrolling in trials is a judgment call based on the devastating effects of disease related to quality of life (QoL) or life-threatening disease. With CMT, the risk-reward is more of a challenging question for many, as CMT in most cases is non-fatal.

Help us answer questions that your doctors and the CMT Research Community aren’t too sure about.

Did you know that you can become part of a community in therapy development and further research for all forms of CMT and inherited neuropathies? The mission of the Global Registry for Inherited neuropathies (GRIN) is to collect clinical and genetic information from patients with ALL forms of Charcot-Marie-Tooth (CMT) and other related rare and ultra rare inherited neuropathies.

Hot off the press

It seems like almost weekly there is another new publication on CMT with interesting basic biology. While an earlier “Hot off the press” highlighted the work of Cherry and co-workers at the University of Texas Southwestern Medical Center who showed show that neurons lacking a gene for rab7 result in neuropathy.

New Study on CMT Type 2B

If we are to learn more about CMT and the effectiveness of rehabilitation it is worth asking the patient and their caregiver. A recent Italian study by Padua et al recently described a survey of CMT patients and caregivers and their perspectives and perceptions of rehabilitation efficacy and needs.

Allison Moore is going to be published!

HNF’s CSO (Chief Scientific Officer), Sean Ekins wrote a blog about his work with Allison Moore and her two “fighter Mom” friends Lori Sames and Jill Wood. He named his blog: “Rare disease heroes – Extraordinary collaborators we should be listening too.” Sean helped my friends and I write a paper called: “Multifaceted roles of ultra rare and rare disease patients/parents in drug discovery.” YES, Allison Moore is going to be published! It will be in Drug Discovery Today, soon. The link to the reprint is below.

Join the conversation

Leave a Comment

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news